268 related articles for article (PubMed ID: 34520132)
1. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer.
Wu C; Zhu J; King A; Tong X; Lu Q; Park JY; Wang L; Gao G; Deng HW; Yang Y; Knudsen KE; Rebbeck TR; Long J; Zheng W; Pan W; Conti DV; Haiman CA; Wu L
Cancer Commun (Lond); 2021 Dec; 41(12):1387-1397. PubMed ID: 34520132
[TBL] [Abstract][Full Text] [Related]
2. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study.
Ohbe H; Hachiya T; Yamaji T; Nakano S; Miyamoto Y; Sutoh Y; Otsuka-Yamasaki Y; Shimizu A; Yasunaga H; Sawada N; Inoue M; Tsugane S; Iwasaki M;
Breast Cancer Res Treat; 2023 Feb; 197(3):661-671. PubMed ID: 36538246
[TBL] [Abstract][Full Text] [Related]
4. netCRS: Network-based comorbidity risk score for prediction of myocardial infarction using biobank-scaled PheWAS data.
Nam Y; Jung SH; Verma A; Sriram V; Won HH; Yun JS; ; Kim D
Pac Symp Biocomput; 2022; 27():325-336. PubMed ID: 34890160
[TBL] [Abstract][Full Text] [Related]
5. Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: evidence from the China Kadoorie Biobank.
Yang S; Sun D; Sun Z; Yu C; Guo Y; Si J; Sun D; Pang Y; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Pang Z; Schmidt D; Stevens R; Clarke R; Chen J; Chen Z; Lv J; Li L;
Chin Med J (Engl); 2023 Oct; 136(20):2476-2483. PubMed ID: 37200020
[TBL] [Abstract][Full Text] [Related]
6. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Darst BF; Shen J; Madduri RK; Rodriguez AA; Xiao Y; Sheng X; Saunders EJ; Dadaev T; Brook MN; Hoffmann TJ; Muir K; Wan P; Le Marchand L; Wilkens L; Wang Y; Schleutker J; MacInnis RJ; Cybulski C; Neal DE; Nordestgaard BG; Nielsen SF; Batra J; Clements JA; Cancer BioResource AP; Grönberg H; Pashayan N; Travis RC; Park JY; Albanes D; Weinstein S; Mucci LA; Hunter DJ; Penney KL; Tangen CM; Hamilton RJ; Parent MÉ; Stanford JL; Koutros S; Wolk A; Sørensen KD; Blot WJ; Yeboah ED; Mensah JE; Lu YJ; Schaid DJ; Thibodeau SN; West CM; Maier C; Kibel AS; Cancel-Tassin G; Menegaux F; John EM; Grindedal EM; Khaw KT; Ingles SA; Vega A; Rosenstein BS; Teixeira MR; ; Kogevinas M; Cannon-Albright L; Huff C; Multigner L; Kaneva R; Leach RJ; Brenner H; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Neuhausen SL; Isaacs WB; Nemesure B; Hennis AJ; Carpten J; Pandha H; De Ruyck K; Xu J; Razack A; Teo SH; ; Newcomb LF; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Usmani N; Claessens F; Gago-Dominguez M; Castelao JE; Townsend PA; Crawford DC; Petrovics G; Casey G; Roobol MJ; Hu JF; Berndt SI; Van Den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Witte JS; Eeles RA; Kote-Jarai Z; Watya S; Gaziano JM; Justice AC; Conti DV; Haiman CA
Am J Hum Genet; 2023 Jul; 110(7):1200-1206. PubMed ID: 37311464
[TBL] [Abstract][Full Text] [Related]
7. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.
Mars N; Koskela JT; Ripatti P; Kiiskinen TTJ; Havulinna AS; Lindbohm JV; Ahola-Olli A; Kurki M; Karjalainen J; Palta P; ; Neale BM; Daly M; Salomaa V; Palotie A; Widén E; Ripatti S
Nat Med; 2020 Apr; 26(4):549-557. PubMed ID: 32273609
[TBL] [Abstract][Full Text] [Related]
8. A principal component approach to improve association testing with polygenic risk scores.
Coombes BJ; Ploner A; Bergen SE; Biernacka JM
Genet Epidemiol; 2020 Oct; 44(7):676-686. PubMed ID: 32691445
[TBL] [Abstract][Full Text] [Related]
9. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
Elife; 2022 Jul; 11():. PubMed ID: 35801699
[TBL] [Abstract][Full Text] [Related]
10. Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank.
Wang L; Desai H; Verma SS; Le A; Hausler R; Verma A; Judy R; Doucette A; Gabriel PE; ; Nathanson KL; Damrauer SM; Mowery DL; Ritchie MD; Kember RL; Maxwell KN
Genet Med; 2022 Mar; 24(3):601-609. PubMed ID: 34906489
[TBL] [Abstract][Full Text] [Related]
11. Efficient Implementation of Penalized Regression for Genetic Risk Prediction.
Privé F; Aschard H; Blum MGB
Genetics; 2019 May; 212(1):65-74. PubMed ID: 30808621
[TBL] [Abstract][Full Text] [Related]
12. Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort.
Shah Y; Kulm S; Nauseef JT; Chen Z; Elemento O; Kensler KH; Sharaf RN
PLoS Comput Biol; 2024 Apr; 20(4):e1011990. PubMed ID: 38598551
[TBL] [Abstract][Full Text] [Related]
13. Leveraging both individual-level genetic data and GWAS summary statistics increases polygenic prediction.
Albiñana C; Grove J; McGrath JJ; Agerbo E; Wray NR; Bulik CM; Nordentoft M; Hougaard DM; Werge T; Børglum AD; Mortensen PB; Privé F; Vilhjálmsson BJ
Am J Hum Genet; 2021 Jun; 108(6):1001-1011. PubMed ID: 33964208
[TBL] [Abstract][Full Text] [Related]
14. Prediction of clinically significant prostate cancer using polygenic risk models in Asians.
Song SH; Kim E; Woo E; Kwon E; Yoon S; Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Investig Clin Urol; 2022 Jan; 63(1):42-52. PubMed ID: 34983122
[TBL] [Abstract][Full Text] [Related]
15. Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks.
Fritsche LG; Patil S; Beesley LJ; VandeHaar P; Salvatore M; Ma Y; Peng RB; Taliun D; Zhou X; Mukherjee B
Am J Hum Genet; 2020 Nov; 107(5):815-836. PubMed ID: 32991828
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations.
Xin J; Du M; Gu D; Jiang K; Wang M; Jin M; Hu Y; Ben S; Chen S; Shao W; Li S; Chu H; Zhu L; Li C; Chen K; Ding K; Zhang Z; Shen H; Wang M
Genome Med; 2023 Jan; 15(1):4. PubMed ID: 36694225
[TBL] [Abstract][Full Text] [Related]
17. Development of a polygenic risk score to improve detection of peripheral artery disease.
Wang F; Ghanzouri I; Leeper NJ; Tsao PS; Ross EG
Vasc Med; 2022 Jun; 27(3):219-227. PubMed ID: 35287516
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of optimal methods and ancestries for calculating polygenic risk scores in East Asian population.
Kim DJ; Kang JH; Kim JW; Cheon MJ; Kim SB; Lee YK; Lee BC
Sci Rep; 2023 Nov; 13(1):19195. PubMed ID: 37932343
[TBL] [Abstract][Full Text] [Related]
19. Towards clinical utility of polygenic risk scores.
Lambert SA; Abraham G; Inouye M
Hum Mol Genet; 2019 Nov; 28(R2):R133-R142. PubMed ID: 31363735
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the use of blood pressure polygenic risk scores across race/ethnic background groups.
Kurniansyah N; Goodman MO; Khan AT; Wang J; Feofanova E; Bis JC; Wiggins KL; Huffman JE; Kelly T; Elfassy T; Guo X; Palmas W; Lin HJ; Hwang SJ; Gao Y; Young K; Kinney GL; Smith JA; Yu B; Liu S; Wassertheil-Smoller S; Manson JE; Zhu X; Chen YI; Lee IT; Gu CC; Lloyd-Jones DM; Zöllner S; Fornage M; Kooperberg C; Correa A; Psaty BM; Arnett DK; Isasi CR; Rich SS; Kaplan RC; Redline S; Mitchell BD; Franceschini N; Levy D; Rotter JI; Morrison AC; Sofer T
Nat Commun; 2023 Jun; 14(1):3202. PubMed ID: 37268629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
